Bluejay Therapeutics is focused on developing innovative cures for infectious diseases with the first target indication of chronic HBV infection.
Investors 2
Date | Name | Website |
- | Octagon Ca... | octagoninv... |
05.09.2022 | Arkin Hold... | arkinholdi... |
Date | Name | Website |
- | Octagon Ca... | octagoninv... |
05.09.2022 | Arkin Hold... | arkinholdi... |